MX2017012433A - Métodos y composiciones para tratamiento de enfermedades inflamatorias e inmunológicas. - Google Patents
Métodos y composiciones para tratamiento de enfermedades inflamatorias e inmunológicas.Info
- Publication number
- MX2017012433A MX2017012433A MX2017012433A MX2017012433A MX2017012433A MX 2017012433 A MX2017012433 A MX 2017012433A MX 2017012433 A MX2017012433 A MX 2017012433A MX 2017012433 A MX2017012433 A MX 2017012433A MX 2017012433 A MX2017012433 A MX 2017012433A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- compositions
- treating inflammatory
- immunological disorders
- treating
- Prior art date
Links
- 208000026278 immune system disease Diseases 0.000 title abstract 2
- 230000002757 inflammatory effect Effects 0.000 title abstract 2
- 208000027866 inflammatory disease Diseases 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 208000024891 symptom Diseases 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 208000038016 acute inflammation Diseases 0.000 abstract 1
- 230000006022 acute inflammation Effects 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 208000037976 chronic inflammation Diseases 0.000 abstract 1
- 230000006020 chronic inflammation Effects 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 230000000813 microbial effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Inorganic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14/670,641 US9999635B2 (en) | 2007-01-16 | 2015-03-27 | Methods and compositions for treating inflammatory disorders |
| PCT/US2016/024453 WO2016160668A1 (en) | 2015-03-27 | 2016-03-28 | Methods and compositions for treating inflammatory and immunological disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2017012433A true MX2017012433A (es) | 2018-03-26 |
Family
ID=57006380
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2017012433A MX2017012433A (es) | 2015-03-27 | 2016-03-28 | Métodos y composiciones para tratamiento de enfermedades inflamatorias e inmunológicas. |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US10617716B2 (https=) |
| EP (1) | EP3273973A4 (https=) |
| JP (1) | JP2018509460A (https=) |
| KR (1) | KR20180012745A (https=) |
| CN (1) | CN107847520A (https=) |
| AU (1) | AU2016243554A1 (https=) |
| CA (1) | CA2980966A1 (https=) |
| HK (1) | HK1250337A1 (https=) |
| IL (1) | IL254671A0 (https=) |
| MX (1) | MX2017012433A (https=) |
| SG (1) | SG11201707892YA (https=) |
| WO (1) | WO2016160668A1 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9381214B2 (en) | 2011-03-18 | 2016-07-05 | Puricore, Inc. | Methods for treating skin irritation |
| EP3233091A4 (en) | 2014-12-16 | 2018-07-18 | Realm Therapeutics, Inc. | Hypochlorous acid formulations and methods for treating skin conditions |
| US10617716B2 (en) | 2014-12-16 | 2020-04-14 | Urgo Us, Inc. | Hypochlorous acid formulations and methods for treating skin conditions |
| US11324734B2 (en) | 2015-04-01 | 2022-05-10 | Akebia Therapeutics, Inc. | Compositions and methods for treating anemia |
| ZA201707084B (en) * | 2016-10-21 | 2018-11-28 | Ultrapure Hocl Pty Ltd | Hypochlorous acid |
| WO2018230743A1 (ja) * | 2017-06-17 | 2018-12-20 | 株式会社エースネット | ラジカル発生触媒、ラジカルの製造方法、酸化反応生成物の製造方法、薬剤および農畜産用薬剤 |
| KR20210005936A (ko) * | 2018-05-02 | 2021-01-15 | 오큐소프트, 인코포레이티드 | 차아염소산 기반 눈꺼풀 세정제 |
| CN112703005A (zh) * | 2018-07-17 | 2021-04-23 | 费灵有限公司 | 包括微生物群恢复治疗（mrt）组合物的联合疗法 |
| EP3993811B1 (en) * | 2019-07-03 | 2025-02-26 | Apr Applied Pharma Research S.A. | Therapeutic uses of oxidising hypotonic acid solutions |
| JP2021171322A (ja) * | 2020-04-24 | 2021-11-01 | ニプロ株式会社 | 次亜塩素酸の呼吸器への導入システム |
| WO2021235506A1 (ja) * | 2020-05-21 | 2021-11-25 | 国立大学法人大阪大学 | 上皮癌治療薬 |
| US20220079981A1 (en) * | 2020-09-15 | 2022-03-17 | Facerestoration Ltd | Lavage techniques and virucidal compositions comprising hypochlorous solutions |
| US20220202853A1 (en) * | 2020-12-28 | 2022-06-30 | Briotech, Inc. | Hypohalous acids for treating inflammatory diseases and inhibiting growth of malignancies |
| GB202110146D0 (en) * | 2021-07-14 | 2021-08-25 | Hypo Stream Ltd | Treatment of respiratory conditions |
| WO2024183061A1 (zh) * | 2023-03-09 | 2024-09-12 | 英属维京群岛商白因子国际股份有限公司台湾分公司 | 一种次氯酸组合物用于制备预防、改善或治疗放射性皮肤炎的医药组合物的用途 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH10236961A (ja) * | 1997-02-25 | 1998-09-08 | Nobel Igaku Kenkyusho:Kk | 電解酸性水を用いた眼科用剤 |
| JP2000063279A (ja) * | 1998-08-07 | 2000-02-29 | Medical Discoveries Inc | 新規免疫機能向上剤 |
| GB2355190B (en) | 1999-08-23 | 2004-07-28 | Sterilox Medical | Improvements in or relating to sterilising preparations |
| US6333054B1 (en) | 1999-10-21 | 2001-12-25 | Amuchina S.P.A. | Topical, non-cytotoxic, antimicrobial hydrogel with thixotropic properties |
| US20030185704A1 (en) * | 2000-01-12 | 2003-10-02 | Suzanne Bernard | Physiologically balanced, ionized, acidic solution and methodology for use in wound healing |
| US9168318B2 (en) * | 2003-12-30 | 2015-10-27 | Oculus Innovative Sciences, Inc. | Oxidative reductive potential water solution and methods of using the same |
| CA2602522C (en) * | 2005-03-23 | 2014-09-09 | Oculus Innovative Sciences, Inc. | Method of treating skin ulcers using oxidative reductive potential water solution |
| EP1959972A4 (en) * | 2005-12-13 | 2009-06-03 | Puricore Inc | PROCESS FOR TREATING OPEN INJURIES BY HYPOCHLOROUS ACID |
| EP1993571B1 (en) * | 2006-01-20 | 2018-07-25 | Sonoma Pharmaceuticals, Inc. | Methods of treating or preventing inflammation and hypersensitivity with oxidative reductive potential water solution |
| CN101405013A (zh) | 2006-01-20 | 2009-04-08 | 奥古露丝创新科学公司 | 使用氧化还原电位水溶液治疗或预防腹膜炎的方法 |
| CA2650973A1 (en) | 2006-05-03 | 2007-11-08 | University Of Manitoba | Microbial markers of inflammatory bowel disease |
| JP4372121B2 (ja) * | 2006-06-24 | 2009-11-25 | 有限会社上川製作所 | 家畜腸内の大腸菌減少剤、家畜体内の脂肪減少剤及び家畜の飼育方法 |
| US9999635B2 (en) | 2007-01-16 | 2018-06-19 | Realm Therapeutics, Inc. | Methods and compositions for treating inflammatory disorders |
| WO2008089268A2 (en) | 2007-01-16 | 2008-07-24 | Puricore, Inc. | Methods and compositions for treating conditions associated with infection and/or inflammation |
| US20100266710A1 (en) * | 2007-07-26 | 2010-10-21 | Mihran Baronian | Pharmaceutical preparations comprising electrochemically activated hypochlorite solutions |
| KR101715631B1 (ko) | 2008-04-01 | 2017-03-13 | 안티포딘 파마슈티칼스, 인코포레이티드 | 피부 관리를 위한 조성물 및 방법 |
| JP2011116730A (ja) * | 2009-12-04 | 2011-06-16 | Yasuharu Shima | 呼吸器系疾患の予防と治療方法 |
| US20120251831A1 (en) * | 2009-12-16 | 2012-10-04 | Japan Carlit Co., Ltd | Near-infrared absorptive coloring matter and near-infrared absorptive composition |
| MX390111B (es) | 2011-03-18 | 2025-03-19 | Urgo Us Inc | Soluciones estabilizadas de acido hipohaloso. |
| US9381214B2 (en) | 2011-03-18 | 2016-07-05 | Puricore, Inc. | Methods for treating skin irritation |
| US10617716B2 (en) | 2014-12-16 | 2020-04-14 | Urgo Us, Inc. | Hypochlorous acid formulations and methods for treating skin conditions |
-
2015
- 2015-12-16 US US15/535,555 patent/US10617716B2/en active Active
-
2016
- 2016-03-28 HK HK18109756.5A patent/HK1250337A1/zh unknown
- 2016-03-28 EP EP16773906.9A patent/EP3273973A4/en not_active Withdrawn
- 2016-03-28 CA CA2980966A patent/CA2980966A1/en not_active Abandoned
- 2016-03-28 AU AU2016243554A patent/AU2016243554A1/en not_active Abandoned
- 2016-03-28 MX MX2017012433A patent/MX2017012433A/es unknown
- 2016-03-28 US US15/562,144 patent/US20180078578A1/en not_active Abandoned
- 2016-03-28 SG SG11201707892YA patent/SG11201707892YA/en unknown
- 2016-03-28 CN CN201680030744.5A patent/CN107847520A/zh active Pending
- 2016-03-28 WO PCT/US2016/024453 patent/WO2016160668A1/en not_active Ceased
- 2016-03-28 JP JP2017550556A patent/JP2018509460A/ja active Pending
- 2016-03-28 KR KR1020177031240A patent/KR20180012745A/ko not_active Withdrawn
-
2017
- 2017-09-25 IL IL254671A patent/IL254671A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20180078578A1 (en) | 2018-03-22 |
| EP3273973A1 (en) | 2018-01-31 |
| US20170360832A1 (en) | 2017-12-21 |
| WO2016160668A1 (en) | 2016-10-06 |
| AU2016243554A1 (en) | 2017-10-19 |
| CN107847520A (zh) | 2018-03-27 |
| CA2980966A1 (en) | 2016-10-06 |
| SG11201707892YA (en) | 2017-10-30 |
| EP3273973A4 (en) | 2018-12-05 |
| US10617716B2 (en) | 2020-04-14 |
| IL254671A0 (en) | 2017-11-30 |
| KR20180012745A (ko) | 2018-02-06 |
| JP2018509460A (ja) | 2018-04-05 |
| HK1250337A1 (zh) | 2018-12-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2017012433A (es) | Métodos y composiciones para tratamiento de enfermedades inflamatorias e inmunológicas. | |
| MX2021000077A (es) | Composiciones que comprenden cepas bacterianas. | |
| BR112018009706A2 (pt) | composições compreendendo cepas bacterianas | |
| AU2019268074A1 (en) | Methods for treating hepcidin-mediated disorders | |
| BR112017025004A2 (pt) | composições compreendendo cepas bacterianas | |
| MX2018006239A (es) | Composiciones que comprenden cepas bacterianas. | |
| MX2018006399A (es) | Composiciones que comprenden cepas bacterianas. | |
| BR112017025003A2 (pt) | composições compreendendo cepas bacterianas | |
| MX2017016529A (es) | Composiciones que comprenden cepas bacterianas. | |
| MX2017016560A (es) | Composiciones que comprenden cepas bacterianas. | |
| PH12017501318B1 (en) | Anti-transthyretin antibodies | |
| MX2019003623A (es) | Composiciones y metodos para el tratamiento de afecciones oftalmicas. | |
| MX2017009803A (es) | Anticuerpos anti-transtiretina. | |
| WO2017091683A8 (en) | Antibody molecules to april and uses thereof | |
| BR112018010089A2 (pt) | composições compreendendo cepas bacterianas | |
| EP3247359A4 (en) | Composition and method for treating seizure disorders | |
| EP3188741A4 (en) | Compositions and methods for the treating an inflammatory disease or disorder | |
| NZ720769A (en) | Anti-siglec-8 antibodies and methods of use thereof | |
| MX373965B (es) | Composiciones de inhibidores de c1 esterasa para usarse en el tratamiento, inhibición, o prevención de angioedema hereditario (hae). | |
| MY193674A (en) | Anti-transthyretin antibodies | |
| MY205689A (en) | Antibody molecules to cd138 and uses thereof | |
| HK1245158A1 (zh) | 阿吡莫德组合物及其使用方法 | |
| EP3186269A4 (en) | Compositions, methods and kits for treating complement related disorders | |
| AU2016362202A8 (en) | Method for preventing or treating nosocomial pneumonia | |
| JOP20140008B1 (ar) | استخدام العوامل المساعدة لمستقبل ألفا 7 أسيتيل كولين نيكوتينية |